BSP Pharmaceuticals S.p.A. was for the first time a sponsor at the Precision Breast Cancer Summit 2016 organized by Neo-Synt.
This summit took place on February 23rd and 24th in Boston, USA, and It brought together 80-100 senior level attendees of the pharmaceutical industry and academia to discuss the most crucial challenges in the development of targeted therapies in Breast Cancer.
Our Technical Business Development Manager presented the speach: ‘INNOVATIVE SERVICES for ANTICANCER DRUGS’ during the first day of the summit.
Breast cancer R&D received the largest amount of spending across all cancer types, and represents the largest opportunity for developers.
The summit covered presentations on the latest updates from the Breast cancer pipelines of small and large drug developers, and feature discussions around all the latest trends in personalized medicine, as pertaining to this disease area, through case studies from early discovery to development.
Topics Include: Antibody Constructs (Including ADC), Immuno-Oncology, Biomarkers and Companion Diagnostics.
